kymera therapeutics(KYMR)发布Q2财报,2025财年前六月累计收入3357.60万美元,去年同期累计收入为3593.70万美元,同比减少6.57%。2025财年前六月累计净亏损1.42亿美元,去年同期累计净亏损为9061.90万美元,同比扩大56.92%。本财年累计基本每股收益为-1.77美元,去年同期为-1.26美元。公司所属行业为生物科技。【公司信息】kymera ...
Source Linkkymera therapeutics(KYMR)发布Q2财报,2025财年前六月累计收入3357.60万美元,去年同期累计收入为3593.70万美元,同比减少6.57%。2025财年前六月累计净亏损1.42亿美元,去年同期累计净亏损为9061.90万美元,同比扩大56.92%。本财年累计基本每股收益为-1.77美元,去年同期为-1.26美元。公司所属行业为生物科技。【公司信息】kymera ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.